v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and Cash Equivalents $ 1,189,223 $ 555,947
Marketable Securities 7,998,891 11,003,071
Prepaid Expenses 884,121 1,106,347
Total Current Assets 10,072,235 12,665,385
Non-Current Assets    
Operating Lease Right-of-Use Assets 132,750 149,009
Goodwill 10,498,539 10,498,539
Investment in Oravax, Inc. 1,500,000 1,500,000
Total Non-Current Assets 12,131,289 12,147,548
Total Assets 22,203,524 24,812,933
Current Liabilities    
Trade and Other Payables 2,418,113 986,626
Operating Lease Liability 48,669 53,240
Total Current Liabilities 2,466,782 1,039,866
Non-Current Liabilities    
Due to MyMD Florida Shareholders 29,982 29,982
Operating Lease Liability, net of current portion 84,619 95,911
Total Non-Current Liabilities 114,601 125,893
Total Liabilities 2,581,383 1,165,759
Commitments and Contingencies  
SHAREHOLDERS’ EQUITY    
Preferred Stock, Value 144,524 144,524
Common stock, no par value, 500,000,000 shares authorized 38,058,245 and 37,673,110 issued and outstanding as of March 31, 2022 and December 31, 2021 102,161,218 102,064,218
Accumulated Deficit (82,683,601) (78,561,568)
Total Shareholders’ Equity 19,622,141 23,647,174
Total Liabilities and Shareholders’ Equity $ 22,203,524 $ 24,812,933

Source